Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

Metoclopramide

metoclopramide
  • Formulary Miscellaneous Program Formulary
  • Restricted Metozolv ODT --> Restricted to patients that cannot take the tablet or solution and do not have an intravenous line.
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Reglan SOLUTION, INJECTABLE 5 mg/mL      
Gimoti SPRAY, NASAL 15 mg      
Reglan SYRUP, ORAL 5 mg/5 mL      
Metozolv ODT TABLET, DISINTEGRATING, ORAL 5 mg      
Reglan TABLET, ORAL 5 mg, 10 mg      


Comments:

Automatic renal adjustment per guidelines. CrCl less than 40 mL/min, use 50% of dose. Renal Adjustment Guidelines

METOZOLV was approved for restricted formulary use in patients that cannot take the tablet or solution and don't have an intravenous line.

GIMOTI (metoclopramide nasal spray): Non-Formulary. Inpatients should use their home supply if necessary.

 


Reviewed: December 2009 (METOZOLV), July 2026 (GIMOTI)


Last updated: Jul. 23, 2026







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.